Hybrid Blepharoplasty is a framework for individualized periorbital surgery—not a fixed package and not a promise of scarless rejuvenation. Dr. June Favarin’s approach evaluates the brow, upper and lower eyelids, lid support, orbital fat, hollows, skin quality, pigmentation, malar edema, festoons, and previous treatments before selecting any surgical component.
Why “hybrid” does not mean doing everything
Different findings require different solutions. Adding procedures without an anatomical indication can increase swelling, dryness, scarring, lid malposition, or an overtreated appearance. Preservation is central: the objective is to improve the responsible structures while maintaining eye shape, expression, and facial identity.
| Finding | Possible component | Important limitation |
|---|---|---|
| Upper-eyelid skin excess | Minimal, measured skin removal | Does not correct brow descent or true ptosis |
| Lower-eyelid bags | Transconjunctival access to selected fat compartments | Does not treat festoons or every dark circle |
| Lower-lid laxity | Selective cantopexy | Not required for every patient |
| Periorbital hollowing | Microfat in selected planes | Retention varies and refinement may be needed |
| Superficial skin quality | Nanofat, CO₂ laser, Morpheus8, or dermatologic treatment | Cannot replace structural surgery |
Upper-eyelid preservation
Conservative upper blepharoplasty removes only the skin supported by the examination and generally preserves the orbicularis muscle. An apparently heavy eyelid may instead reflect brow descent, frontalis compensation, loss of volume, or true ptosis. Mild ptosis may require a conjunctivo-Müller approach in selected patients.
Lower-eyelid planning
Dr. June generally favors a transconjunctival, bi-incisional lower-eyelid approach to access the three fat compartments while avoiding a routine external lower-lid incision. Fat may be conserved, adjusted, or complemented with microfat according to the lid–cheek transition. This does not eliminate risks or guarantee that no external skin treatment will be indicated.
Fillers, edema, and dermatologic ultrasound
Previous hyaluronic-acid filler, biostimulators, threads, PMMA, silicone, and energy treatments must be documented. Filler can persist and may contribute to edema, but dissolving it is not automatically required in every patient. Dermatologic ultrasound can identify material, location, and tissue response when examination or history is uncertain. See injectables before facial surgery.
Risks and recovery
Swelling, bruising, tearing, dryness, light sensitivity, temporary blurred vision from ointment, and early asymmetry can occur. Risks include bleeding, infection, chemosis, lagophthalmos, visible scars, lid malposition, persistent dryness, diplopia, fat-graft irregularity, pigment change, and the rare risk of visual loss. Sudden pain, rapidly expanding swelling, or a change in vision requires emergency evaluation.
Patients usually become progressively more presentable over the first weeks, but residual edema and scars mature for months. Read more about blepharoplasty recovery and warning signs.
International-patient planning
The final plan is confirmed in person. Belvivere coordinates hospital care when appropriate, postoperative reviews, and practical support through its concierge service. Travel clearance depends on healing rather than a guaranteed date.
